Objectives: Oxidative stress is involved in cystic fibrosis (CF), but no guidelines for its assessment or its treatment exist. Our aim was to evaluate a test that measures the whole antioxidant capability in CF children.
Introduction
It was already demonstrated that oxidative stress was involved in the pathophysiology of cystic fibrosis (CF), while recurrent pulmonary infections, chronic pulmonary inflammation and abnormal lung epithelium homeostasis increase the release of oxidative molecules, and antioxidants like micronutrients and fat-soluble vitamins are decreased [1] [2] [3] [4] . However, no guidelines are established for the follow-up of oxidative stress or antioxidant potential in clinical practice in CF.
Oxidative stress is defined as an abnormal oxidant/antioxidant balance, secondary to either an increase of oxidants or a decrease of antioxidants [1] . In CF, large amounts of reactive oxygen species (ROS) are released by neutrophils that are present in bronchial lumen [1] . Other sources of ROS come from bronchial cilated and alveolar type II epithelial cells, and Pseudomonas aeruginosa [1] . These ROS alter bacteria phagocytosis. ROS are second messengers that can activate, through NF-B pathway, the transcription of inflammatory cytokines, mainly IL-6 and IL-8 [1] . Oxidants can also increase lipid peroxidation, producing several pro-inflammatory lipid mediators.
Oxysterols, which are produced by oxidation of cholesterol, are increased in CF [7] . The oxidation of arachidonic acid (AA) produces acid 8-isoprostane prostaglandin F2 [8] . Plasma level of this eicosanoid is increased after pulmonary exacerbations [8] . The imbalance is also due to a decreased level of glutathione (GSH), an impaired NO metabolism, and an abnormal intracellular H2O2 production [1] . Antioxidants present at respiratory surface are ascorbate, urate, -tocopherol, GSH, and mucins [6] . GSH is the only antioxidant present in larger amount in epithelial lining fluid than in plasma; however GSH levels 5 are decreased to 5-10% in epithelial lining fluid and to 50% in plasma of CF patients [6] .
Nutritional status is important in CF management. It is associated with both pulmonary status and survival [9] . In the setting of oxidative stress, protein malnutrition contributes to decreased albumin level and secondarily to low GSH levels [6] . Albumin can not provide all cysteine required for GSH production [6] . Pancreatic insufficiency causes malabsorption of fat-soluble antioxidants such as carotenoids, vitamin E, and coenzyme Q-10 [1, 6] . There is also an abnormal fatty acid pattern in CF that is characterized by a decrease in the plasma levels of linoleic acid and docosahexaenoic acid (DHA) and an increase in the levels of AA and eicosapentaenoic acid [10, 11] . These abnormalities are present even in well-nourished children, suggesting an involvement of the protein CFTR in fatty acid metabolism rather than fat malabsorption [11] . AA promotes the production of inflammatory mediators while 3 polyunsaturated fatty acids (PUFA), DHA and eicosapentaenoic acid (EPA), are involved in the resolution of inflammation [1, 12] . Around 90% of CF patients require pancreatic enzyme replacement therapy (PERT) and fatsoluble vitamin supplementation. However, the amount of antioxidant vitamin supplementation could be different to obtain normal plasma vitamin levels or to correct oxidant/antioxidant balance [5, 6] . For example, CF Foundation recommends 40-400 IU/d of vitamin E to normalize plasma levels [13] . To reach an antioxidant effect, 1600 IU/d of vitamin E were required in hypercholesterolemic subjects [1] . However, some studies reported that highdosage vitamin E supplementation increased risk of heart failure, coagulopathy, and death [6, 14] . Carotenoid supplementation had also positive results on 6 oxidative stress in CF trials. Vitamin E and carotenoid induced a decrease of markers of lipid peroxidation, like 8-isoprostane prostaglandin F2 and malondialdehyde respectively [6] . However, the clinical relevance of these improvements is unknown. Of note, large cancer prevention trials that used -tocopherol and -carotene (ATBC trial) or -carotene and retinyl palmitate (CARET trial) lead to an excess lung cancer incidence and an excess mortality in the active vitamin treatment arm [15] . The cardiovascular mortality was also increased. Finally, micronutrient deficiencies, mainly selenium and zinc, which are frequent in CF, can alter the function of enzymatic antioxidants [1, 6] . Zinc is a cofactor of superoxide dismutase and selenium is en essential component of GSH peroxidase and thioredoxin reductases [6] .
Oxidative stress can be assessed by several biomarkers [1, 5, 6] . The aim of this study was to use a test that measured the whole antioxidant capability in CF children, using a rapid and standardized test (KRL test). We also looked for a correlation with appropriate clinical, biochemical, and radiological parameters. We recorded the anthropometric parameters and FEV1 values obtained 6 months before to look for patient evolution prior to oxidative stress analysis.
We calculated the evolution of BMI z-score and FEV1 during this period, respectively (z-BMI -z-BMI M-6 )/ z-BMI M-6 and (FEV1 -FEV1 M-6 )/ FEV1 M-6 , respectively defined as BMIev and FEV1ev. 
Data analysis
Numerical data were expressed as mean  SD (minimum-maximum). A descriptive analysis of the main patient's clinical and biological characteristics (displayed in Table 1 ) was performed using a principal component analysis with varimax rotation. Univariate analysis was performed with non-parametric tests, Mann-Whitney test and Spearman correlation test. Then factors independently associated with T1/2 erythro/T1/2 whole blood were identified using stepwise multiple linear regression models (entry threshold: F test pvalue <0.1). All these analyses were performed on 44 cases, i.e. one per patient. When more than one analysis was performed for one patient, we chose the first measure. Then, a second multivariate analysis was performed on all available measures using linear models fitted with the Generalized Estimating Equation method. We therefore analysed 72 cases, accounting for the nonindependence of measures among patients who had more than one oxidative stress evaluation. We used the SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). All tests were two-sided and considered statistically significant at p<0.05.
Results

Description of the population
In this study, 44 children (24 boys and 20 girls) were included. The mean age at the first KRL assessment was 12.2  3.8 (5.9-19.1). Clinical characteristics of these children were reported on Table 1 . Among these children, 5 (11.4%) had a z-BMI lower than -2; the H/W ratio was lower than 85% in 7 children (15.9%), between 85-90% in 3 children (7%). None of these malnourished children was on enteral feeding at that time. Ninety-one percent of these patients were pancreatic insufficient. They were supplemented with vitamin A (43%), vitamin E (91%) and selenium (64%) according to their respective blood values. Forty-three percent of patients were on ursodeoxycholic acid treatment.
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Their respiratory status was correct. The mean value of FEV1 was 94% (Table 1) . Only 2 patients had a FEV1 ≤ 50 %. Congestion and exacerbation were reported respectively in 57% and 14% of the visits. Pseudomonas aeruginosa was found in 16% of the cultures performed in all of the visits. Table 2 .
Oxidative status
The mean of T1/2 whole blood (n=72) was 90.3  11.4 min (68.5- 
Principal component analysis
The plane identified by the first two factorial axes, was found to explain 38% of the total inertia in the data (Figure 1) . The variables that are close to one of the axes are correlated together. For example, the first factorial axis (factor 1) was mainly positively correlated to FEV1 and retinol/RBP, and mainly negatively correlated to orosomucoid, ceruloplasmin, triglycerides, and Brasfield score. The second factorial axis (factor 2) was mainly positively 12 correlated to retinol, pre-albumin, and RBP. Inversely, the principal component analysis should suggest that age and GGT were not correlated to the other variables.
Univariate analysis (Table 3)
There is an association between sex and antioxidant potential. T1/2 whole blood and T1/2 erythro were significantly shorter in females than males, 92.2 ± 12.4 vs. 88.4 ± 10.2 min (p=0.011), and 75.0 ± 11.5 vs. 68.9 ± 17.2 min (p=0.052) respectively. There was no correlation of T1/2 whole blood or T1/2 erythro with age, and anthropometric parameters. We did not find any difference between CF patients who were treated or not with antioxidants (vitamin A, vitamin E, ursodeoxycholic acid (UDCA), or selenium). The amount of PERT was negatively correlated to T1/2 erythro (ρ=-0.36, p=0.039).
As it could be expected, the levels of selenium in the serum were positively correlated to T1/2 erythro (ρ=0.35, p=0.047) and T1/2 whole blood (ρ=0.44, p=0.004). Concerning PUFA of membrane phospholipids of erythrocytes, the 6/3 ratio was negatively correlated to T1/2 erythro (ρ=-0.37, p=0.030).
However, there was no correlation with levels of PUFA (DHA, EPA, and AA), retinol, and -tocopherol.
Pulmonary functional tests revealed that only FEV1 was positively correlated to T1/2 erythro (ρ=0.39, p=0.018). Concerning the pulmonary infectious diseases of these patients, Pseudomonas aeruginosa colonisation was not correlated to antioxidant potential. However, patients that were on itraconazole treatment had lower antioxidant potential than patients that were not, statistically significant for T1/2 erythro, 65.7 ± 12.6 min vs. 75.8 ± 14.9 min (p=0.025). To note, these patients were not treated with itraconazole for 13 acute broncho-pulmonory aspergillosis but for chronic colonisation. A shorter time of T1/2 erythro was found for acute exacerbation and congestion, 73.3 ± 15.7 min vs. 65.2 ± 5.3 min (p=0.022) and 76.1 ± 18.6 min vs. 68.7 ± 10.1 min (p=0.009). Finally, Brasfield score was negatively correlated to T1/2 eryhtro (ρ=-0.48, p=0.03) and T1/2 whole blood (ρ=-0.32, p=0.036).
We expected a negative correlation of antioxidant potential with inflammatory proteins. If there was a trend with C-reactive protein (CRP) and T1/2 erythro (p=0.063), we found a negative correlation of inflammatory proteins with T1/2 erythro: orosomucoid (ρ=-0.62, p<0.001) and ceruloplasmin (ρ=-0.57, p<0.001). The number of blood leucocytes was negatively associated with T1/2 whole blood (ρ=-0.36, p=0.018) and T1/2 erythro (ρ=-0.39, p=0.025).
Multivariate analysis
For T1/2 erythro, 3 parameters were independently associated:
Brasfield score, 6/3 ratio, and levels of selenium in the serum. However, this latter parameter could be excluded when we analysed all the results of KRL test performed for the same patient. Finally, Brasfield score and 6/3 ratio remained independently negatively correlated to T1/2 erythro, β=-0.611 (p<0.001) and β=-1.213 (p=0.013) respectively. For T1/2 whole blood, 2 parameters were independently associated: sex and MMEF. After accounting for all the available measures, only the sex remained significantly correlated to T1/2 whole blood (p=0.015).
Discussion:
The KRL test represents the capability of a person to react to an oxidative stress. In our study, T1/2 erythro was significantly associated with a decrease of plasma level of selenium. The decrease of this antioxidant could alter the selenium-dependant GSH peroxidase, as it was reported [1] . T1/2 erythro was also associated with pulmonary congestion and exacerbation, i.e. may be with an increase of ROS in the lungs. To our knowledge, the correlation of oxidative stress and Brasfield score was not previously described.
In our study, this score was the only respiratory parameter that remained statistically significant in multivariate analysis. More than air trapping, this association could be due to bronchiectasis. In the literature, oxidative stress was present during acute respiratory exacerbations and it improved after treatment of exacerbation [18] . The oxidation of proteins that were present in bronchoalveolar lavage fluids was negatively correlated to FEV1 values [19] .
However, oxidative stress remains present in stable CF patients and it could also contribute to chronic pulmonary inflammation [5] . Similarly, a recent study assessed plasma and cellular oxidative stress biomarkers in stable adults with bronchiectasis (36 CF, and 54 without CF), and in 50 healthy controls [20] . Oxidative stress biomarkers were increased in patients with bronchiectasis compared with controls, without difference between CF and not CF patients.
The relation of good nutritional status and pulmonary function is well established [21] . We did not find any association between antioxidant capability, assessed by the KRL test, and anthropometric parameters. However, the fact that the amount of PERT was associated in univariate analysis with 15 T1/2 erythro should suggest that pancreatic insufficiency by itself rather than clinical nutritional status is involved in oxidative stress in CF. Lezo et al. recently reported that CF patients with pancreatic insufficiency had higher levels of lipid peroxidation biomarkers than patients with pancreatic sufficiency [5] . We did not find any significant differences between oxidative stress and fat-soluble vitamins. The antioxidant capabilities of patients that were not treated with antioxidant vitamins were similar to those of supplemented patients. Abnormalities of fatty acids that occurs in CF seems to be of importance [7, 10] . In multivariate analysis, we found a significant negative correlation of 6/3 ratio and T1/2 erythro. The increase of 6/3 ratio is associated with a decrease of antioxidant potential of CF patients, with synthesis of pro-inflammatory lipid mediators and reduction of resolvins, involved in the resolution of inflammation [12] . A limitation of our study is that we did not test these lipid mediators, but they were not routinely available.
In further studies, we should assess plasma levels of protaglandins (PGE2), leucotriens (LTB4), and eicosanoids (5-HETE) that are the products of the oxidation of AA by cyclooxygenase and 5-lipoxygenase. They could be of better interest than AA, EPA, and DHA levels that were not associated with oxidative stress in our study. However, ratio of 6/3 or AA/DHA could be of greater importance than the quantity of fatty acids [7, 10] .
In order to effectively manage oxidative stress in CF, we could hypothesize that: (i) plasma antioxidant normal values are too low in the setting of CF; (ii) antioxidant levels within the airway are more important than the plasma levels; (iii) trials are needed to determine appropriate antioxidant regimen [5, 6] . New formulations of fat-soluble vitamins and antioxidants have been tested since few years [22, 23] . The formulation increased plasma levels of -carotene, -tocopherol and CoQ-10. Improvement of their antioxidant score was correlated to a decreased airway inflammation assessed by levels of IL-8 and total neutrophils in sputum. This score combined the values of these levels of several antioxidants pre and post-treatment. However, this score was complex and only determined in 10 patients. Moreover, pre and post-levels of IL-8 and especially total neutrophils only decreased in few patients [22] . The formulation is now commercialised as AquADEKs®, a formulation containing several fat-soluble vitamins, water-soluble vitamins, micronutrients, and
antioxidants. An open-label non-randomised study enrolled 14 CF patients [23] .
The authors only found an improvement of plasma levels of some antioxidants (-carotene, CoQ-10, and -tocopherol). No correlation was found with urine 8-isoprostane levels. In recent reviews, details on antioxidant trials in CF were summarized [1, 6] . Our data suggest that the KRL test is an interesting tool to assess antioxidant potential in CF. Moreover, its correlation with pulmonary status could dispense of the measure of BAL oxidative biomarkers that are more invasive. This test could allow to follow the antioxidant potential of CF children and to monitor the effectiveness of antioxidant intervention.
In conclusion, the present study demonstrated that the whole antioxidant capability, measured by the KRL test, should be a useful biomarker to assess oxidative stress in CF patients. It was associated with pulmonary status. The better respiratory parameter correlated to antioxidant potential was Brasfield score. The efficiency of the KRL test was greater in erythrocytes than in whole blood cells. This study should suggest that 6/3 ratio could be more relevant than fat-soluble antioxidant vitamin levels to assess oxidative stress in 17 CF. Finally, an interventional trial is required to evaluate the usefulness of this test to detect post-treatment improvements.
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